Search Tag: tranexamic acid

ICU Management

2024 12 Mar

  A recent study aimed to assess the effectiveness and safety of tranexamic acid in treating acute upper gastrointestinal bleeding (UGIB) in patients with cirrhosis, particularly those classified as Child-Turcotte-Pugh (CTP) class B and C. These patients experience systemic and localised fibrinolysis in the mucosa of the oesophagus and stomach....Read more

ICU Management

2023 01 Aug

There is a lack of evidence-based haemostatic treatment for intracerebral haemorrhage (ICH) associated with non-vitamin K antagonist oral anticoagulants (NOACs). Tranexamic acid (TXA) is an antifibrinolytic drug that helps limit haematoma expansion.   A study was conducted to evaluate the effectiveness and safety of using TXA in NOAC-related ICH...Read more

ICU Management

2019 19 Oct

According to new research findings, early treatment with tranexamic acid could reduce deaths in traumatic brain injury patients by as much as 20%. The findings are published in The Lancet.  Every year, there are approximately 60 million new cases of TBI worldwide. Bleeding in or around the brain due to tearing of blood vessels is a common complication...Read more

Executive Health Management

2015 13 Sep

  The use of an economical drug for hip or knee replacements since 2013 has helped St. Michael's Hospital in Ontario, Canada reduce the number of transfusions performed during these surgeries by more than 40 percent without negatively affecting any patients.  “Having a coordinated blood management program is a very great value in limiting unnecessary...Read more